-
-
-
-
-
-
-
ProQR Therapeutics (PRQR) Reiterated at Market Outperform by Citizens on AX-0810 Potential
-
-
-
-
-
-
-
ProQR (PRQR) Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP
-
-
-
-
-
-
-
Citi Upgrades ProQR Therapeutics N.V. (PRQR) to Buy
-
-
-
-
-
479,045 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


